Oncotarget is a peer-reviewed journal that focuses on the pathological basis of all cancer types, potential therapy targets as well as treatment protocols that are employed in order to enhance the management of individuals suffering from cancer. Oncotarget is also committed to the impact of new therapeutic agents, management programs and protocols on perspectives of patients such as adherence, life and also satisfaction. The medical journey which mostly focuses on Oncology also explores the evidence that is behind the existing and new therapies when it comes to enhancing outcomes. Oncotarget was launched in 2010 and is usually published by the Impact Journals.The Editors in Chief at Oncotarget are Mikhail Blagosklonny and Andrei Gudkov.
The two Editors in Chief also serve as scientists at the Roswell Park Cancer Institute. Oncotarget is a member of COPE (Committee on Publication Ethics) and also subscribes to the organization’s principles. The Journal Impact Factor of Oncotarget is currently 1.653 and is projected to be 2.612 by September 2017. Since its inception, the medical journal has managed to acquire a huge following which is international. Oncotarget is normally abstracted also indexed in MEDLINE/PubMed, Science Citation Index Expanded, Scopus, Index Medicus and BIOSIS Previews. The rising popularity of Oncotarget has been attributed to its constructive, multiple peer-review, insightful and punctual approach.The medical journal has assisted its authors to enhance their research impact.
Following its success on oncology, Oncotarget has decided to now accept papers which are on topics other than oncology. The topics include Cell Biology, Endocrinology, Pharmacology and all its areas, Metabolism, Cardiology, Neuroscience and many others. Oncotarget as a term encompasses all cellular functions, pathways and molecules that are common in aging and cancer, microbes and cancer cells, neurons and lymphocytes as well as atherosclerosis and neurodegeneration. Oncotarget hopes to make results of science widely and rapidly available. It also seeks to make the impact maximum through its perceptive review.Through the leadership of prominent and skilled scientists, Oncotarget assists all scientific researchers in contributing to the science progress. The ultimate vision of the medical journal is to see people all over the world live a life without disease.